By Pete Nieves
“It’s easy for a company to say that they operate based on a valuable mission, but how many companies actually do, and are then repeatedly recognized for it?”
What are the possibilities when a mission drives a company? It’s a question that all great brands must ask and prioritize. Over the past several months, Teladoc and Best Doctors have been committed to unifying our business in light of a shared mission – to provide a new and better healthcare experience. For some companies, an acquisition can be laden with major hurdles to growth, but when there is top down alignment, a focus on the mission, and a true passion to make it a reality, incredible results can be achieved.
At Teladoc, we’ve recently had the great fortune of receiving Read more
Best Doctors, a division of Teladoc, has been awarded ‘Best Added Value Service’ at the prestigious COVER Excellence Awards, one of the UK’s leading publications covering life, health and protection insurance.
This is a new category which has been included this year, acknowledging the growing importance of ‘add on’ services.
The annual awards ceremony, held in London, seeks to recognise and reward firms and intermediaries who have been continuing to innovate and serve customers to the highest standards. The awards review intermediaries and service providers across 23 different categories and are rigorously judged by a panel of leading experts from the protection and PMI industry.
Dominic Howard, Director Europe for Best Doctors said: “We are thrilled to win such a wonderful accolade for our business. In a highly competitive market this award recognises Read more
Breast cancer remains the most common cancer in women worldwide and as the World Cancer Research Fund International highlights; this accounts for 12% of new cancer diagnosis each year and represents 25% of all cancers that affect females. It is estimated that worldwide over 508,000 women died in 2011 due to breast cancer (Global Health Estimates, WHO 2013).
Breast Cancer around the world
The breast cancer incidence rates, measured by the number of cases per 100,000 females, are far lower in developing countries than in the west but death rates are astoundingly higher. The incidence rates greatly range from to 89.7/100,000 in Western Europe to 19.3/100,000 in Eastern Africa. According to GLOBOAN (2008), developing countries have incidence rated below 40/100,000 but survival rates are shockingly lower than other parts of the world like Europe, USA and Japan.
North America, Sweden and Japan’s breast cancer survival rates are 80% or higher. This figure drops to 60% in middle-income countries and further Read more